Screener
Arcus Biosciences RCUS Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Marketable securities | 552 | 759 |
| Receivable from collaboration partners | 36 | 11 |
| Prepaid expenses and other current assets | 18 | 15 |
| Total current assets | 756 | 1,007 |
| Long-term marketable securities | 73 | 29 |
| Property and equipment, net | 36 | 40 |
| Other noncurrent assets | 59 | 63 |
| Total assets | $924 | $1,139 |
Item 1. Financial Statements
FAQ
- What is Arcus Biosciences's total current assets?
- Arcus Biosciences (RCUS) reported total current assets of $756M in Q2 2026.
- How has Arcus Biosciences's total current assets changed year-over-year?
- Arcus Biosciences's total current assets decreased by 20.1% year-over-year, from $946M to $756M.
- What is the long-term trend for Arcus Biosciences's total current assets?
- Over 5 years (2020 to 2025), Arcus Biosciences's total current assets has grown at a 6.5% compound annual growth rate (CAGR), from $735.82M to $1.01B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Arcus Biosciences's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude